CONMED Corporation
CNMD
$57.08
-$0.67-1.16%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -82.12% | -31.09% | 63.41% | 52.09% | -40.40% |
| Total Depreciation and Amortization | 9.92% | -7.61% | 0.76% | -1.10% | 10.65% |
| Total Amortization of Deferred Charges | -49.26% | 97.09% | 2.63% | -0.07% | -56.03% |
| Total Other Non-Cash Items | 8.20% | 176.15% | -3,910.02% | -129.42% | 184.05% |
| Change in Net Operating Assets | 102.66% | -2,075.52% | 122.16% | 52.94% | -304.17% |
| Cash from Operations | -4.16% | -15.36% | 18.24% | 48.71% | -48.36% |
| Capital Expenditure | 6.46% | -18.16% | 4.76% | -76.41% | 58.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 27.50% | -18.16% | 4.76% | -76.41% | 58.08% |
| Total Debt Issued | 10.67% | 4.90% | -29.90% | -19.69% | 41.11% |
| Total Debt Repaid | 2.91% | -10.06% | 26.52% | 3.36% | -8.18% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.05% | -0.23% | -0.08% | -0.08% | -0.07% |
| Other Financing Activities | 14.20% | -33.37% | 44.09% | 55.60% | -112.90% |
| Cash from Financing | 44.39% | -31.52% | 11.92% | -159.11% | 71.05% |
| Foreign Exchange rate Adjustments | 136.63% | -446.67% | 204.54% | -20.27% | -150.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 178.71% | -245.95% | 292.50% | -152.16% | 254.03% |